Table A2.
Response | Cy/GVAX Plus CRS-207 (n = 61) |
Cy/GVAX (n = 29) |
||
---|---|---|---|---|
No. | % | No. | % | |
CR | 0 | 0 | 0 | 0 |
PR | 0 | 0 | 0 | 0 |
SD | 19 | 31 | 7 | 24 |
PD | 31 | 51 | 15 | 52 |
NE | 2 | 3 | 1 | 3 |
Missing* | 9 | 15 | 6 | 21 |
Abbreviations: CR, complete response; Cy, cyclophosphamide; NE, not evaluable; PD, progressive disease; PR, partial response; SD, stable disease.
Clinical progression before week-10 response assessment.